Ketner, PNAS 1994, 91: 6186-6190.* |
Borst (Journal of Virology 1999 73 (10) pp. 8320-8329.* |
Mocarski J Gen Virol. 1987 pp. 2223-2230.* |
Demmler, G.J., 1994 Congenital cytomegalovirus infection, Semin. Pediatr. Neurol. 1(1):36-42. |
Daniel, Y., et al., 1995, Congenital cytomegalovirus infection,Eur. J. Obstet. Gynecol. Reprod. Biol., 63(1):7-16. |
Alford and Britt, “The Human Herpesviruses”, Eds. Roizman, B., R. J. Whitley and C. Lopez, Raven Press, New York, 1993, pp 227-55. |
Pritchett, R. F., 1980, DNA nucleotide sequence heterogeneity betweeen the Towne and AD169 strains of cytomegalovirus, J. Virol. 36(1):152-61. |
Lehner, R. et al., 1991, Comparative sequence analysis of human cytomegalovirus strains, J. Clin. Microbiol. 29(11):2494-502. |
Fries, B. C., 1994, Frequencvy distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients, J. Infect. Dis. 169(4):769-74. |
Condie, R. M. et al., 1984, Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globuin, Birth Defects, 20:327-344. |
Perrillo, R. P. et al., 1987, Immune globulin and hepatitis B immune globulin, Arch. Intern Med., 144:81-85. |
Snydman, D. R., et al. 1987, Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients, N. Engl. J. Med., 317:1049-1054. |
P Plotkin, S. A., et al., 1984, Towne-Vaccine-Induced Prevention of Cytomegalovirus Disease After Renal Transplants, Lancet, 1:528-30. |
Plotkin, S. A. et al., 1976, Clinical Trial of Immunization of theTowne 125 Strain of Human Cytomegalovirus, J. Infect. Dis., 134:470-75. |
Glazer, J. P. et al., 1979, Live Cytomegalovirus Vaccination of Renal Transplant Candidates: A Preliminary Trial, Ann. Intern. Med., 91:676-83. |
Cranage, M. P. et al., 1968, Identification of the Human Cytomegalovirus Glycoprotein B Gene and Induction of Neutroalizing Antibodies via its Expression in RecombinantVaccinia Virus, EMBO J., 5:3057-3063. |
Johnson, D. C. et l., 1988, Abundant Expresson of Herpes Simplex VirusGlycoprotein gB using an Adenovirus Vector, Virol., 164:1-14. |
Dewar, R. L. et al., 1988, Synthesis and Processing of Human Immunodeficiency Virus Type 1 Envelope Proteins Encoded by a Recombinant Human Adenovirus, J. Virol., 63:129-136. |
Davis, A. R. et al., 1985, Expression of Hepatitis B Surface Antigen with a Recombinant Adenovirus, Proc. Natl. Acad. Sci., U.S.A., 82:7560-7564. |
Morin, J. E. et al., 1987, Recombinant Adenovirus Induces Antibody response to Hepatitis B Virus Surface Antigen in Hamsters, Proc. Natl. Acad. Sci., U.S.A., 84:4626-4630. |
Takajuji, E. T. et al., 1970, Simultaneous Administration of Live, Enteric-CoatedAdenovirus Types 4,7, and 21 Vaccines: Safety andImmungenicity,J. Infect. Dis., 140:48-53. |
Collis, P. B. et al., 1973, Adenovirus Vaccines in Military Recruit Populations: A Cost-Benefit Analysis, J. Inf. Dis., 128:74-750. |
Messerle, M., et al. 1997, Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A., 94: 14759-14763. |
Schlessinger, D. 1990, Yeast artificial chromosomes: tools for mapping and analysis of complex genomes, Trends In Genetics 6:248-253. |
Choi, T. K. et al., 1993, Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome. Nature Gen. 4:117-123. |
Ramsay, M. 1994, Yeast artificial chromosome cloning. Mol. Biotech. 1:181-201. |
Nemani M. et al., 1994, A YAC contig in 6p23 based on sequence tagged sites,Genomics 53: 388-396. |
Derossi, D. et al., 1994, The Third Helix of the Antennapedia Homeodomain Translocates through Biological Membranes, The Journal of Biological Chemistry269: 10444-10450. |
McVoy, M. A. et al., 1993, Human Cytomegalovirus DNA Replicates after EarlyCircularization by Concatemer Formation, and Inversion Occurs within theConcatemer,J. Virol. 68:1040-1051. |
Lukac, D. M., et al., 1994, Transcriptional Activation by the Human Cytomegalovirus Immediate-Early Proteins: Requirements for Simple Promoter Structures and Interactions with Multiple Components of the Transcription Complex. |
Furnari, B. A., et al., 1993, Human Cytomegalovirus Immediate-Early Gene 2 Protein Interacts with Itself and with Several Novel Cellular Proteins,J. Virol. 67 (8):4981-4991. |
Hagemeier, C., et al., 1992, The Human Cytomegalovirus 80-Kilodalton but Not the 72-Kilodalton Immediate-Early Protein Transactivates Heterologous Promoters in a TATA Box-Dependent Mechanism and Interacts Directly with TFIID. J. Virol. 66 (7): 4452-4456. |
Jupp, R., et al., 1993, Human Cytomegalovirus IE86 Protein Interacts with Promoter-Bound TATA-Binding Protein via a Specific Region Distinct from the Autorepression Domain J. Virol. 67 (12): 7539-7546. |
Angulo, A. et al., 2000, Identification of a Boundary Domain adjacent to the Potent HumanCytomegalovirus Enhancer that Represses Transcription of the Divergent UL127 Promoter J. Virol. 14: 2826-2839. |
Garcia-Ramirez, J. J., et al 2001 Jan., Dominance of Virus over Host Factors in Cross-species Activation of Human Cytomegalovirus Early Gene Expression,J Virol, 75(1): 26-35. |
Tamachiro, J. C. et al., 1986, Terminal structure and heterogencity in human cytomegalovirus strain AD169, JVirol. 59: 591-604. |
Kemble G., et al., 1989, A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus A sequence, J. Virol. 63: 4715-4728. |
Ibanez C. E., et al., 1991, Human Cytomegalovirus Productivity Infects Primary Differential MacrophagesJ. of Virology65: 6581-6588. |
Smith, D. R. et al. 1999, Amplification of large artificial chromosomes,Proc. Natl. Acad. Sci. 87: 8242-8246. |
“Human herpesvirus 5, genome” Accession: NC-001347 http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?db−genome&gi−10043. |
“Human adenovirus A, complete genome” Accession: NC-001460 http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?db−genome&gi−10190. |
“Simian immunodeficiency virus, complete genome” Accession: NC-001549 http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?db−genome&gi−10371. |
“Human immunodeficiency virus 1, complete genome” Accession: NC-001802 http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?db−genome&gi−12171. |
“Mouse cytomegalovirus 1, complete genome” Accession: NC-004065 http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?db−genome&gi−16530. |
Brune, W., et al., “Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis,” Nature Biotechnology, 17:360-364, (Apr. 1999). |
Mahoney, T.J., et al. “Construction and Manipulation of an Infectious Clone of the Bovine Herpesvirus 1 Genome Maintained as a Bacterial Artificial Chromosome,” J. of Virology, 76(13):6660-6668 (Jul. 2002). |
McGregor, A. and Schleiss, M.R., “Recent Advances in Herpesvirus Genetics Using Bacterial Artificial Chromosomes,” Mol. Gen. and Metab., 72:8-14 (2001). |
McGregor, A. and Schleiss, M.R., “Molecular Cloning of the Guinea Pig Cytomegalovirus (GPCMV) Genome as an Infectious Bacterial Artificial Chromosome (BAC) in Escherichia coli,” Mol. Gen. and Metab., 72:15-26 (2001). |
Monaco, A.P. and Larin, Z., “YACs, BACs, PACs, and MACs: artificial chromosomes as research tools,” TIBTECH, 12:280-286 (Jul. 1994). |
Smith, G.A. and Enquist, L.W., “A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis,” Proc. Natl. Acad. Sci. USA, 97(9):4873-4878 (Apr. 2000). |
Wagner, M., et al., “Systematic Excision of Vector Sequences from the BAC-Cloned Herpesvirus Genome during Reconstitution,” J. of Virology, 73(8):7056-7060 (Aug. 1999). |
Yu, D., et al., “Construction of a Self-Excisable Bacterial Artificial Chromosome Containing the Human Cytomegalovirus Genome and Mutagenesis of the Diploid TRL/IRL13 Gene,” J. of Virology, 76(5):2316-2328 (Mar. 2002). |
Horsburgh, B.C., et al., “Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes,” Gene Therapy 6(5):922-930, May 1999. |
Kemble, G., et al., “Defined Large-Scale Alteration of the Human Cytomegalovirus Genome Constructed by Contransfection of Overlapping Cosmids,” Journal of Virology 70(3):2044-2048, Mar. 1996. |